Gary T. Shearman

1.8k total citations
50 papers, 1.4k citations indexed

About

Gary T. Shearman is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Gary T. Shearman has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Gary T. Shearman's work include Neuroscience and Neuropharmacology Research (19 papers), Receptor Mechanisms and Signaling (14 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Gary T. Shearman is often cited by papers focused on Neuroscience and Neuropharmacology Research (19 papers), Receptor Mechanisms and Signaling (14 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Gary T. Shearman collaborates with scholars based in United States, Germany and Switzerland. Gary T. Shearman's co-authors include Harbans Lal, A. Herz, Albert Herz, H. Lal, R Przewłocki, David Stephens, W. Kehr, Richard C. Ursillo, Robert W. Dunn and Mark S. Scheller and has published in prestigious journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics and Anesthesiology.

In The Last Decade

Gary T. Shearman

50 papers receiving 1.3k citations

Peers

Countries citing papers authored by Gary T. Shearman

Since Specialization

Citations

This map shows the geographic impact of Gary T. Shearman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary T. Shearman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary T. Shearman more than expected).

Fields of papers citing papers by Gary T. Shearman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary T. Shearman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary T. Shearman. The network helps show where Gary T. Shearman may publish in the future.

Co-authorship network of co-authors of Gary T. Shearman

This figure shows the co-authorship network connecting the top 25 collaborators of Gary T. Shearman. A scholar is included among the top collaborators of Gary T. Shearman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary T. Shearman. Gary T. Shearman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Effects of Dizocilpine Maleate (MK-801), an Antagonist of the N-Methyl-D-Aspartate Receptor, on Neurologic Recovery and Histopathology following Complete Cerebral Ischemia in Primates 1990 ·Journal of Cerebral Blood Flow & Metabolism ·William L. Lanier, William J. Perkins, (unknown), James H. Milde, Bernd W. Scheithauer, Gary T. Shearman, John D. Michenfelder	67
2	The noncompetitive N-methyl-d-aspartate receptor antagonist, MK-801 profoundly reduces volatile anesthetic requirements in rabbits 1989 ·Neuropharmacology ·Mark S. Scheller, Mark H. Zornow, Jerry E. Fleischer, Gary T. Shearman, Thomas Greber	56
3	Evaluation of the glutamate antagonist dizocilipine maleate (MK-801) on neurologic outcome in a canine model of complete cerebral ischemia: correlation with hippocampal histopathology 1989 ·Brain Research ·John D. Michenfelder, William L. Lanier, Bernd W. Scheithauer, William J. Perkins, Gary T. Shearman, James H. Milde	46
4	MK-801, an Excitatory Amino Acid Antagonist, Does Not Improve Neurologic Outcome following Cardiac Arrest in Cats 1989 ·Journal of Cerebral Blood Flow & Metabolism ·Jerry E. Fleischer, Akio Tateishi, John C. Drummond, Mark S. Scheller, Marjorie R. Grafe, Mark H. Zornow, Gary T. Shearman, Harvey M. Shapiro	58
5	CY 208–243: A unique combination of atypical opioid antinociception and D1 dopaminomimetic properties 1988 ·Life Sciences ·(unknown), Heinz H. Büscher, D. Römer, Richard A. Maurer, Albert Enz, Beat H. Gähwiler, Gary T. Shearman, Max P. Seiler, (unknown)	13
6	Discriminative stimulus properties of muscarinic agonists 1987 ·Psychopharmacology ·M. Jung, L. Costa, Gary T. Shearman, Peter H. Kelly	16
7	Discriminative stimulus effects of tizanidine hydrochloride: Studies with rats trained to discriminate either tizanidine, clonidine, diazepam, fentanyl, or cocaine 1987 ·Drug Development Research ·Gary T. Shearman	4
8	Effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on 5-HTP-induced head shaking and behavioral symptoms induced by 5-methoxy-N,N,dimethyltryptamine in rats: comparison with some other 5-HT receptor antagonists 1987 ·Psychopharmacology ·Gary T. Shearman, L. Tolcsvai	7
9	Bremazocine-induced backwards walking behavior in rats in mediated via opioid kappa receptors 1986 ·Pharmacology Biochemistry and Behavior ·Gary T. Shearman, Carina Stenfors	7
10	The κ opioid receptor and food intake 1985 ·European Journal of Pharmacology ·John E. Morley, Allen S. Levine, Julie Kneip, Martha K. Grace, Horst Zeugner, Gary T. Shearman	47
11	Opioid antinociception and positive reinforcement are mediated by different types of opioid receptors 1983 ·Life Sciences ·(unknown), Tommaso Costa, Gary T. Shearman, A. Herz, Larry D. Reid	18
12	Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats 1983 ·Neuropeptides ·R Przewłocki, Gary T. Shearman, A. Herz	120
13	Analgesic effects of μ-, δ- and κ-opiate agonists and, in particular, dynorphin at the spinal level 1983 ·Life Sciences ·Ryszard Przewłocki, (unknown), (unknown), Gary T. Shearman, Barbara Przewłocka, A. Herz	75
14	Ethanol and tetrahydroisoquinoline alkaloids do not produce narcotic discriminative stimulus effects 1983 ·Psychopharmacology ·Gary T. Shearman, Albert Herz	9
15	Lack of evidence for a role of endorphinergic mechanisms in mediating a discriminative stimulus produced by diazepam in rats 1982 ·Psychopharmacology ·Gary T. Shearman, Mark J. Millan, Albert Herz	8
16	Attenuation of chemically induced anxiogenic stimuli as a novel method for evaluating anxiolytic drugs: A comparison of clobazam with other benzodiazepines 1982 ·Drug Development Research ·Harbans Lal, Gary T. Shearman	28
17	A comparison of the antidiarrheal and some other pharmacological effects of clonidine, lidamidine, and loperamide in the rat 1981 ·Drug Development Research ·Harbans Lal, Gary T. Shearman	14
18	Effectiveness of Nantradol in Blocking Narcotic Withdrawal Signs Through Nonnarcotic Mechanisms 1981 ·The Journal of Clinical Pharmacology ·Harbans Lal, Debra A. Bennett, Gary T. Shearman, (unknown), (unknown), (unknown)	7
19	Nonnarcotic Antidiarrheal Action of Clonidine and Lofexidine in the Rat 1981 ·The Journal of Clinical Pharmacology ·Harbans Lal, Gary T. Shearman, Richard C. Ursillo	28
20	Differential reduction of morphine-withdrawal body shakes by butaclamol enantiomers 1978 ·Life Sciences ·Martin D. Hynes, (unknown), Gary T. Shearman, Harbans Lal	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact